HBK Investments’s GSK GSK Stock Holding History

HBK Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-79,922	Closed	-$4.17M	–	791
2019 Q1	$4.17M	Buy	+79,922	New	+$3.99M	0.04%	364
2018 Q1	–	Sell	-8,208	Closed	-$364K	–	1028
2017 Q4	$364K	Sell	8,208 -8,819	-52%	-$407K	﹤0.01%	818
2017 Q3	$864K	Sell	17,027 -25,133	-60%	-$1.28M	0.01%	671
2017 Q2	$2.27M	Buy	+42,160	New	+$2.25M	0.01%	383
2017 Q1	–	Sell	-60,160	Closed	-$2.9M	–	728
2016 Q4	$2.9M	Buy	+60,160	New	+$2.97M	0.03%	282
2016 Q2	–	Sell	-29,902	Closed	-$1.52M	–	999
2016 Q1	$1.52M	Sell	29,902 -53,378	-64%	-$2.66M	0.01%	499
2015 Q4	$4.2M	Buy	+83,280	New	+$4.24M	0.04%	254
2014 Q4	–	Sell	-62,400	Closed	-$3.59M	–	1037
2014 Q3	$3.59M	Buy	+62,400	New	+$3.83M	0.06%	260

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

HBK Investments's GSK Position: Q2 2019 in Review

HBK Investments sold out of GSK (GSK) in Q2 2019, closing a stake of 79,922 shares — an estimated $4.17M sold.

HBK Investments first reported a position in GSK in Q3 2014 and held it in 8 quarters. The position peaked at $4.2M in Q4 2015. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

HBK Investments reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
HBK Investments sold 79,922 GSK shares in Q2 2019, an estimated $4.17M.
HBK Investments first reported a position in GSK in Q3 2014 and held it in 8 quarters.
HBK Investments's GSK position peaked at $4.2M in Q4 2015.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.